U.S. Markets closed

ETF investment opportunities amid Pfizer's deal with Mylan

Investors are eyeing the pharmaceutical industry on the heels of Pfizer's new deal with Mylan. Dave Nadig, ETF.com Managing Director, joins Akiko Fujita on 'The Ticker' to discuss where to find innovation in the ETF space.